We are live on ! Find out more

340 hedge funds and large institutions have $4.31B invested in Bruker in 2025 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 112 increasing their positions, 129 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.42% more ownership

Funds ownership: 81.98%87.39% (+5.4%)

9% more call options, than puts

Call options by funds: $21.2M | Put options by funds: $19.4M

8% less funds holding

Funds holding: 370340 (-30)

13% less repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 129

16% less capital invested

Capital invested by funds: $5.12B → $4.31B (-$810M)

30% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 90

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
340
Holders Change
-30
Holders Change %
-8.11%
% of All Funds
4.45%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
63
Increased
112
Reduced
129
Closed
90
Calls
$21.2M
Puts
$19.4M
Net Calls
+$1.78M
Net Calls Change
+$23.7M

BRKR Hedge Fund Activity: Q3 2025 in Review

340 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Bruker (BRKR) for Q3 2025, worth a combined $4.31B — down 16% from $5.12B a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of BRKR and 63 opened new positions — a net loss of 27 holders — while 129 trimmed existing stakes and 112 added.

The largest buyer was Orbis Allan Gray, adding an estimated $337M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $180M.

  • 340 institutional investors held Bruker (BRKR) as of Q3 2025, down from 370 in Q2 2025.
  • Funds reported $4.31B of Bruker stock for Q3 2025, down 16% quarter-over-quarter.
  • 63 funds opened new Bruker positions in Q3 2025 and 90 closed out, a net change of -27 holders.
  • The largest Bruker buyer in Q3 2025 was Orbis Allan Gray, an estimated $337M added.
  • The largest Bruker seller in Q3 2025 was T. Rowe Price Investment Management, an estimated $180M sold.

Based on aggregated 13F filings for Q3 2025.